Home LiteratureArticle Details
PMID: 9765440 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.

Journal of virology ·Vol. 72 ·No. 11 ·1998-11-00 ·Pages 8952-60

Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB

Abstract

Chemokine receptors CCR5 and CXCR4 are the primary fusion coreceptors utilized for CD4-mediated entry by macrophage (M)- and T-cell line (T)-tropic human immunodeficiency virus type 1 (HIV-1) strains, respectively. Here we demonstrate that HIV-1 Tat protein, a potent viral transactivator shown to be released as a soluble protein by infected cells, differentially induced CXCR4 and CCR5 expression in peripheral blood mononuclear cells. CCR3, a less frequently used coreceptor for certain M-tropic strains, was also induced. CXCR4 was induced on both lymphocytes and monocytes/macrophages, whereas CCR5 and CCR3 were induced on monocytes/macrophages but not on lymphocytes. The pattern of chemokine receptor induction by Tat was distinct from that by phytohemagglutinin. Moreover, Tat-induced CXCR4 and CCR5 expression was dose dependent. Monocytes/macrophages were more susceptible to Tat-mediated induction of CXCR4 and CCR5 than lymphocytes, and CCR5 was more readily induced than CXCR4. The concentrations of Tat effective in inducing CXCR4 and CCR5 expression were within the picomolar range and close to the range of extracellular Tat observed in sera from HIV-1-infected individuals. The induction of CCR5 and CXCR4 expression correlated with Tat-enhanced infectivity of M- and T-tropic viruses, respectively. Taken together, our results define a novel role for Tat in HIV-1 pathogenesis that promotes the infectivity of both M- and T-tropic HIV-1 strains in primary human leukocytes, notably in monocytes/macrophages.

MeSH Terms
Base Sequence Cells, Cultured DNA Primers/genetics Dose-Response Relationship, Drug Gene Expression/drug effects Gene Products, tat/genetics,pharmacology,physiology HIV Infections/etiology,virology HIV-1/genetics,pathogenicity,physiology Humans Macrophages/drug effects,virology Monocytes/drug effects,virology Phytohemagglutinins/pharmacology Receptors, CCR3 Receptors, CCR5/biosynthesis,genetics Receptors, CXCR4/biosynthesis,genetics Receptors, Chemokine/biosynthesis,genetics Recombinant Proteins/administration & dosage,genetics,pharmacology T-Lymphocytes/drug effects,virology tat Gene Products, Human Immunodeficiency Virus
Chemicals
CCR3 protein, human DNA Primers Gene Products, tat Phytohemagglutinins Receptors, CCR3 Receptors, CCR5 Receptors, CXCR4 Receptors, Chemokine Recombinant Proteins tat Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Huang L
Divisions of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. lhuang@mbccrr.harvard.edu
Bosch I
Hofmann W
Sodroski J
Pardee A B
References (63)
63 references, click to expand
  1. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
    Science. 1997 Apr 11;276(5310):273-6 PMID: 9092480
  2. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection.
    J Virol. 1998 Jan;72(1):830-6 PMID: 9420295
  3. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.
    Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8116-20 PMID: 9223324
  4. Macrophage tropism: fact or fiction?
    J Leukoc Biol. 1997 Jul;62(1):4-11 PMID: 9225986
  5. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus.
    J Virol. 1997 Sep;71(9):6928-34 PMID: 9261420
  6. Co-receptors for HIV-1 entry.
    Curr Opin Immunol. 1997 Aug;9(4):551-62 PMID: 9287172
  7. Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1 beta.
    Clin Exp Immunol. 1995 Nov;102(2):430-7 PMID: 7586702
  8. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis.
    J Immunol. 1996 Feb 15;156(4):1638-45 PMID: 8568270
  9. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  10. Identification of a major co-receptor for primary isolates of HIV-1.
    Nature. 1996 Jun 20;381(6584):661-6 PMID: 8649511
  11. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
    Nature. 1996 Jun 20;381(6584):667-73 PMID: 8649512
  12. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.
    Cell. 1996 Jun 28;85(7):1135-48 PMID: 8674119
  13. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.
    Cell. 1996 Jun 28;85(7):1149-58 PMID: 8674120
  14. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha.
    Immunology. 1996 May;88(1):55-60 PMID: 8707350
  15. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Science. 1996 Jun 28;272(5270):1955-8 PMID: 8658171
  16. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    J Virol. 1996 Sep;70(9):6288-95 PMID: 8709256
  17. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes.
    J Immunol. 1996 Aug 1;157(3):974-7 PMID: 8757599
  18. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
    Cell. 1996 Aug 9;86(3):367-77 PMID: 8756719
  19. Chemoattractants attract HIV researchers.
    J Exp Med. 1996 Aug 1;184(2):311-3 PMID: 8760784
  20. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes.
    J Exp Med. 1996 Aug 1;184(2):569-77 PMID: 8760810
  21. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
    Nature. 1996 Aug 22;382(6593):722-5 PMID: 8751444
  22. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes.
    J Immunol. 1996 Sep 1;157(5):2216-24 PMID: 8757349
  23. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
    Science. 1996 Sep 27;273(5283):1856-62 PMID: 8791590
  24. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
    Nat Med. 1996 Nov;2(11):1240-3 PMID: 8898752
  25. CCR5 is characteristic of Th1 lymphocytes.
    Nature. 1998 Jan 22;391(6665):344-5 PMID: 9450746
  26. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes.
    J Exp Med. 1998 Feb 2;187(3):439-44 PMID: 9449724
  27. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
    J Virol. 1998 Apr;72(4):2855-64 PMID: 9525605
  28. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5461-4 PMID: 7777531
  29. Viral latency in HIV disease.
    Cell. 1995 Jul 28;82(2):183-8 PMID: 7628009
  30. Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line.
    Eur J Immunol. 1995 Sep;25(9):2695-700 PMID: 7589147
  31. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10(3):306-16 PMID: 7552492
  32. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells.
    Blood. 1995 Nov 15;86(10):3823-34 PMID: 7579350
  33. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.
    Science. 1997 Mar 7;275(5305):1481-5 PMID: 9045614
  34. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1925-30 PMID: 9050881
  35. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes.
    J Exp Med. 1997 Mar 3;185(5):969-74 PMID: 9120403
  36. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes.
    J Immunol. 1997 Apr 1;158(7):3378-84 PMID: 9120297
  37. Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes.
    J Immunol. 1983 Aug;131(2):743-8 PMID: 6223092
  38. Loss of circulating T4+ monocytes in patients infected with HTLV-III.
    Lancet. 1986 Feb 1;1(8475):270 PMID: 2868277
  39. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes.
    J Immunol. 1989 Feb 1;142(3):773-80 PMID: 2521508
  40. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.
    Proc Natl Acad Sci U S A. 1989 Feb;86(3):821-4 PMID: 2536934
  41. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.
    J Virol. 1990 May;64(5):2416-20 PMID: 2325207
  42. HIV-1 replication is controlled at the level of T cell activation and proviral integration.
    EMBO J. 1990 May;9(5):1551-60 PMID: 2184033
  43. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
    Cell. 1990 Apr 20;61(2):213-22 PMID: 2331748
  44. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat.
    J Cell Biol. 1990 Sep;111(3):1275-81 PMID: 2202737
  45. Endocytosis and targeting of exogenous HIV-1 Tat protein.
    EMBO J. 1991 Jul;10(7):1733-9 PMID: 2050110
  46. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.
    J Virol. 1992 Dec;66(12):7159-67 PMID: 1279199
  47. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
    J Virol. 1993 Jan;67(1):277-87 PMID: 8416373
  48. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  49. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    Nature. 1993 Mar 25;362(6418):359-62 PMID: 8096068
  50. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals.
    Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5549-53 PMID: 8516299
  51. Tat and the HIV-1 promoter.
    Curr Opin Cell Biol. 1993 Jun;5(3):461-8 PMID: 8352964
  52. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
    Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7941-5 PMID: 7690138
  53. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.
    J Virol. 1993 Dec;67(12):7238-45 PMID: 8230446
  54. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    J Exp Med. 1994 Mar 1;179(3):961-71 PMID: 8113688
  55. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.
    J Virol. 1994 Jul;68(7):4177-85 PMID: 8207793
  56. Macrophage-tropic HIV: critical for AIDS pathogenesis?
    Immunol Today. 1994 Jul;15(7):332-9 PMID: 7916189
  57. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.
    Science. 1995 Apr 21;268(5209):429-31 PMID: 7716549
  58. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
    Nature. 1995 Jun 8;375(6531):497-500 PMID: 7539892
  59. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
    Nat Med. 1997 Oct;3(10):1160-2 PMID: 9334732
  60. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.
    AIDS. 1997 Oct;11(12):1421-31 PMID: 9342064
  61. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.
    J Immunol. 1997 Oct 15;159(8):4077-83 PMID: 9378998
  62. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.
    J Virol. 1997 Dec;71(12):8999-9007 PMID: 9371556
  63. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
    J Exp Med. 1997 May 5;185(9):1681-91 PMID: 9151905
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-11-00
Pages
8952-60
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC110312
Subset
IM
Grants
NCI NIH HHS · T32 CA009361 · United States
NCI NIH HHS · 2-T32-CA09361 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com